Letter to the editors in response to: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic (Cure et al.)


Ekiz T., KARA M., ÖZÇAKAR L.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, cilt.14, sa.4, ss.525-526, 2020 (ESCI) identifier identifier identifier